Abstract
The aim of this study was to establish the prevalence of anemia in stable pediatric renal transplant recipients and to examine the association of anemia with renal function, immunosuppressants, angiotensin converting enzyme inhibitors, and growth, as well as iron, vitamin B12, and folate stores. This is a cross-sectional study of the 50 renal transplant recipients currently followed at our center. Patient data were collected regarding hematological parameters, growth, medications, renal function, underlying renal disease, delayed graft function, episodes of rejection, and iron or erythropoietin therapy post transplantation. The mean hemoglobin level (Hb) was 110 g/l and the overall prevalence of anemia was 60%, including 30% who were severely anemic (Hb<100 g/l). There was a high rate of iron deficiency (34%) and serum iron was the parameter of iron metabolism most closely associated with anemia. Hb in patients with low serum iron was 90.7 g/l versus 114.4 g/l in those with normal serum iron (P<0.01). Both univariate and multiple linear regression determined tacrolimus dose and creatinine clearance to be significant factors associated with anemia. Tacrolimus dose correlated with a 10 g/l reduction in Hb for every increase of tacrolimus dose of 0.054 mg/kg per day (P=0.001). The dose of mycophenolate was positively correlated with Hb, but this was likely to be confounded by our practice of dose reduction in the setting of anemia. Angiotensin converting enzyme inhibitor use was not associated with anemia. Severely anemic patients tended to be shorter, with a mean Z-score for height of –1.8 compared with –0.9 for those with normal Hb (P=0.02). Anemia is a significant and common problem in pediatric renal transplant patients. Deteriorating renal function is an important cause, but other factors like iron deficiency and immunosuppression are involved. Definition of iron deficiency is difficult and serum iron may be a valuable indicator. Medication doses, nutritional status, need for erythropoietin and iron, as well as poor graft function and growth require systematic scrutiny in the care of the anemic renal transplant recipient.
Similar content being viewed by others
References
Miles A, Markell M, Daskalakis P, Sumrani N, Hong J, Sommer B, Friedman E (1997) Anaemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 11:313–315
Nampoory M, Johny K, Al-Hilali N, Seshadri M, Kanagasabhapathy A (1996) Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function. Nephrol Dial Transplant 11:177–181
Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais AL, Vincenti S, Vincenti F (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3:835–845
Yorgin P, Belson A, Sanchez J, Al Uzri A, Sarwal M, Bloch D, Oehlert J, Salvatierra O, Alexander S (2002) Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40:1306–1318
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Bain B (1989) Blood cells a practical guide. Gower Medical
Dacie JV, Lewis SM (eds) (1995) Practical haematology, 8th edn. Churchill Livingstone, Edinburgh
Hall R, Malia RG (eds) (1984) Medical laboratory haematology. Butterworth, London
Nathan DG, Oski FA (eds) (1993) Haematology of infancy and childhood, 4th edn. Saunders, Philadelphia
Oski FA, Naiman JL (eds) (1982) Hematologic problems in the newborn, 3rd edn. Saunders, Philadelphia
Williams (ed) (1996) Hematology, 5th edn.
Wintrobe MM (ed) (1993) Clinical hematology, 9th edn. Lea and Febiger, London
Burtis CA, Ashwood ER (1994) Tietz textbook of clinical chemistry, 2nd edn. Saunders, Philadelphia
Cole T, Freeman J, Preece M (1998) British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 17:407–429
Stata (2003) Stat Statistical Software: Release 8.0. College Station, Texas
Peter C, Latta K, Graf D, Offner G, Brodehl J (1998) Does tacrolimus cause more severe anaemia than cyclosporin A in children after renal transplantation? Transpl Int 11 [Suppl 1]:S328–S330
Saito S, Fujiwara T, Sakagami K, Matsuno T, Tanaka N (1998) Anaemia following renal transplantation. Transplant Proc 30:3025–3026
Arbeiter K, Greenbaum L, Balzar E, Muller T, Hofmeister F, Bidmon B, Aufricht C (1998) Reproducible erythroid aplasia caused by mycophenolate mofetil. Pediatr Nephrol 14:195–197
Gossman J, Thurmann P, Bachmann T, Weller S, Kachel H, Schoeppe W, Scheuermannn E (1996) Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int 50:973–978
Gaston RS, Julian BA, Diethelm, Curtis JJ (1991) Effect of enalapril on erythrocytosis after renal transplantation. Ann Intern Med 115:954–955
Stigant C, Cohen J, Vovera M, Zaltman J (2000) ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 35:58–63
Muirhead N (1999) Erythropoietin and transplantation. Kidney Int 55 [Suppl 69]:S86–S92
Schaeffer R, Schaeffer L (1999) Evaluation of iron status in renal failure patients. Kidney Int 55 [Suppl 69]:S44–S48
Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl W, Sunder-Plassman G (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13:794–797
CARI guidelines (2000) Caring for Australians with renal impairment: biochemical and haematological targets. Guideline 7, pp 19–26
Al-Uzri A, Yorgin P, Kling P (2003) Anaemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant 7:253–264
Hokken-Koelega A, Stijnen T, Ridder M de, Muinck Keizer-Schrama F de, Wolff E, Jong M de, Donckerwolcke R, Groothoff J, Blum W, Drop S (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343:1313–1317
Hokken-Koelega A, Zaal E van, Bergen W van, Stijnen T, Ridder M de, Wolff E de, Jong C de, Donckerwolcke R, Muinck Keizer-Schrama F de, Drop S (1994) Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 36:323–328
Guest G, Bérard E, Crosnier H, Chevallier T, Rappaport R, Broyer M (1998) Effects of growth hormone in short children after renal transplantation. Pediatr Nephrol 12:437–446
Ninik A, McTaggart S, Gulati S, Powell H, Jones C, Walker R (2002) Factors influencing growth and final height after renal transplantation. Pediatr Transplant 6:219–223
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kausman, J.Y., Powell, H.R. & Jones, C.L. Anemia in pediatric renal transplant recipients. Pediatr Nephrol 19, 526–530 (2004). https://doi.org/10.1007/s00467-004-1427-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1427-y